Abstrak
Several prognosis factors of metastasis into the pelvic lymph node of cervical carcinoma include, among others, primary lesion size, histological type, and degrees of cell differentiation. Metastasis into lymph node reduces 5-year survival by 35%, and the administration of adjuvant therapy of radiation would increase 5-year survival by 5%. 1 The results of surgical therapy are similar to those of radiation therapy, such that patients with early stage cervical cancer that has metastasized into pelvic lymph node should be administered radiation therapy. Metastatic process occurs through stages of metastasis, one of which is endothelial proliferation in angiogenesis process. VEGF-C, a member of the VEGF family, contitutes one of the growth factors that plays a role in the proliferation of endothelial cells, and the increase of VEGF-C expression would raise the VEGF-C level. Thus, it was of interest to study whether there was an increase of VEGF-C levels in patients with early stage cervical cancer that had metastasized into lymph node. This study aimed to prove and identify the sensitivity and specifi city of the examination of VEGF-C level in detecting metastasis of cervical carcinoma into pelvic lymph node.
METHODS
Design of this study was a case-control study in which the cases were cervical cancers with metastasis into pelvic lymph node, and controls who were cervical cancer patients without metastasis into pelvic lymph node. Samples of the study were patients with stage IB-IIA cervical cancer undergoing radical hysterectomy. Independent variables analyzed were, among others, VEGF level, primary lesion size, histological type, differentiation degree, and lymph vascular space invasion. On the other hand, dependent variable analyzed was, among others, metastasis into pelvic lymph node. VEGF-C level was measured by means of ELISA examination with value unit of pg/ml.
RESULTS
As many as 47 cases met the criteria of the study. On normality test, it could be concluded that data of VEGF-C levels with Chi2 test and Saphiro-Wilk were distributed in accordance with normal data distribution (p=0.14244). 
Bivariate analysis

VEGF-C Characteristics
Based on the calculation of sensitivity and specifi city and ROC analysis for VEGF-C, we found a cut point of 10,066.90 pg/ml. Patients with serum VEGF-C levels >10,066.90 pg/ml were at risk for metastasis into pelvic lymph node (odds ratio, OR 80) as high as that of serum VEGF-C level ≤ 10,066.90 with CI of 7.99;800.71 and p value = 0.000. Table 3 . Correlation between VEGF-C level and stage of the disease and primary lesion size Five-year survival could increase to 55% if patients received post-surgical adjuvant therapy of radiation when the tumor had metastasized into pelvic lymph node. 4, 5 Detection of tumor metastasis into lymph node is relatively diffi cult to do and expensive (CT scan or MRI examination). Therefore, it is necessary to have an examination method capable of detecting metastasis of cervical cancer into pelvic lymph node which is feasible to perform and affordable. VEGF is a growth factor playing a role in the angiogenesis process which constitutes part of the metastasis process. The increase of VEGF levels would stimulate the activity of angiogenesis. 6 In our study, there were 4 variables which in bivariate analysis affected the incidence of metastasis of stage IB-IIA cervical cancer into pelvic lymph node, i.e. variables of VEGF-C, primary lesion size, lymph vascular space invasion, and cell differentiation degree. Primary lesion > 4 cm constituted one of the prognosis factors of tumor metastasis into pelvic lymph node.
Multivariate analysis
The incidence of cervical cancer metastasis into pelvic lymph node in stage IB-IIA cervical cancers with primary lesion size > 4 cm was approximately 35.2%. On the other hand, metastasis incidence in primary lesion < 4 cm was approximately 21.1%. 1 Lymph vascular space invasion was a tumor embolus in lymph vessels or blood vessels which indicated the presence of tumor invasion into lymph vessels or blood vessels. Tumor emboli in lymph vessels or blood vessels would increase the risk of tumor metastasis. 7 Cell differentiation degree showed some cell changes, and in good differentiation degree no cell changes had been found to deviate from the mother cells. By contrast, tumors with poor differentiation degree showed enormous cell changes from the mother cells. Such changes showed tumor aggressiveness, tumors with poor differentiation degree were generally aggressive with unfavorable radiation therapy or chemotherapy. Compared with tumors of moderate or good differentiation, tumors with poor differentiation degree were more unfavorable in terms of survival.
VEGF is one of the proteins playing a role in the process of angiogenesis and lymph genesis. The process of angiogenesis and lymph genesis contitutes an important part in the incidence of metastasis and survival of tumor cells, such that VEGF expression affects the incidence of angiogenesis and lymph genesis. Lymph genesis represents a series of metastatic processes of lymphogene into lymph node. 8 The enhanced expression of VEGF would increase the incidence of angiogenesis and lymph genesis as well as VEGF level in the blood. The enhanced expression of VEGF also serves as a sign for the increased incidence of either hematogene or lymphogene metastases. Thus, it was of interest to study the correlation between VEGF levels and the incidence of metastasis into pelvic lymph node. 9, 10, 11 On multivariate analysis, VEGF-C level contitutes a variable that has a correlation with the incidence of metastasis into pelvic lymph node. Therefore, VEGF-C represents a stronger predictive variable of metastasis into pelvic lymph node than other variables and a VEGF level >10,066.90 pg/ml indicates metastasis of cervical cancer into pelvic lymph node. By using a cut off point of 10,066.90 pg/ml the sensitivity of the VEGF-C level in relation to the risk for the incidence of lymph node metastasis in this study is 71.43%, with specifi city of 96.97%, a positive predictive value (PPV) of 90.91%, and a negative predictive value of 88.89%. The results of this study show that VEGF-C level can be used to predict the presence or absence of cervical cancer metastasis into pelvic lymph node. Examination of VEGF-C levels can be performed as screening criteria for the cases appropriate for immediate surgery.
In conclusion, VEGF-C level >10,066.90 pg/ml indicates a risk for developing metastasis of cervical cancer into pelvic lymph node and this value can be used to predict such metastasis with a sensitivity of 71.43%, specifi city of 96.9%, a positive predictive value of 90.91%, and negative predictive value of 88.89%.
